Sort by
Refine Your Search
-
To strengthen our team in the division "Polymer Matrix Composites" in Berlin‑Steglitz, starting as soon as possible, we are looking for a Research Associate (m/f/d) –Damage mechanics and structural
-
the ISS team and will collaborate closely not only with members of the D&E Group but also with the Mechanical Engineering Group on various technical matters and projects, particularly those involving
-
chemistry team in a lab-based role in Bothell Washington to support novel ADC technology development. The successful candidate will participate in research projects involving the design and synthesis of novel
-
Plan, execute and analyze in vivo pharmacology studies Characterize new in vivo mouse models, including syngeneic tumor and genetically engineered mouse (GEM) models, to study biologic mechanisms and
-
chemistry team in a lab-based role in Bothell Washington to support novel ADC technology development. The successful candidate will participate in research projects involving the design and synthesis of novel
-
Development laboratories based in Groton, CT. As part of the Applied Synthesis and Technology (AST) Group, the successful applicant will contribute to the execution of synthetic technologies (compound library
-
of Medicine, New York, USA. The scientist will perform NIH-funded research projects that dissect molecular mechanisms of retinal differentiation and inherited retinal degenerations, contributing to therapeutic
-
identification and analysis. Supervise and guide a small team of scientists Develop and characterize new in vivo mouse models, including cell-line derived xenografts, syngeneic tumor and genetically engineered
-
Development laboratories based in Groton, CT. As part of the Applied Synthesis and Technology (AST) Group, the successful applicant will contribute to the execution of synthetic technologies (compound library
-
, drug mechanisms-of-actions, and biomarkers. We are dedicated to the development of oncology agents that disrupt cancer biology or redirect the immune system against cancer cells, and we leverage